Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mercaptamine 0.55% eye drops
1108010A0AAACAC
|
Mercaptamine hydrochloride (Eye) | Mercaptamine hydrochloride | Eye | 12 |
|
Mercaptamine 0.5% eye drops
1108010A0AAAAAA
|
Mercaptamine hydrochloride (Eye) | Mercaptamine hydrochloride | Eye | 3 |
|
Cystadrops 3.8mg/ml eye drops
1108010A0BBAAAF
|
Cystadrops | Mercaptamine hydrochloride | Eye | 2 |
|
Mercaptamine 0.55% eye drops preservative free
1108010A0AAAEAE
|
Mercaptamine hydrochloride (Eye) | Mercaptamine hydrochloride | Eye | 1 |
|
Mercaptamine 3.8mg/ml eye drops
1108010A0AAAFAF
|
Mercaptamine hydrochloride (Eye) | Mercaptamine hydrochloride | Eye | 1 |
|
Mercaptamine 0.11% eye drops
1108010A0AAABAB
|
Mercaptamine hydrochloride (Eye) | Mercaptamine hydrochloride | Eye | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.